223 related articles for article (PubMed ID: 37408396)
1. [Cardiac amyloidosis: pathological classification and clinical analysis of 48 cases].
Yu TP; Hou J; Yang TJ; Lei S; Yang M; Su YY; Chen YC; Wu Y; Chen XQ
Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):671-677. PubMed ID: 37408396
[No Abstract] [Full Text] [Related]
2. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
[TBL] [Abstract][Full Text] [Related]
3. [Classification of cardiac amyloidosis: an immunohistochemical analysis].
Li L; Duan XJ; Sun Y; Lu Y; Xu HY; Wang QZ; Wang HY
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):105-109. PubMed ID: 29429161
[No Abstract] [Full Text] [Related]
4. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
Damy T; Jaccard A; Guellich A; Lavergne D; Galat A; Deux JF; Hittinger L; Dupuis J; Frenkel V; Rigaud C; Plante-Bordeneuve V; Bodez D; Mohty D
Amyloid; 2016 Sep; 23(3):194-202. PubMed ID: 27647161
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P
ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887
[TBL] [Abstract][Full Text] [Related]
6. Myocardial Edema and Prognosis in Amyloidosis.
Kotecha T; Martinez-Naharro A; Treibel TA; Francis R; Nordin S; Abdel-Gadir A; Knight DS; Zumbo G; Rosmini S; Maestrini V; Bulluck H; Rakhit RD; Wechalekar AD; Gilbertson J; Sheppard MN; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
J Am Coll Cardiol; 2018 Jun; 71(25):2919-2931. PubMed ID: 29929616
[TBL] [Abstract][Full Text] [Related]
7. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
Arvanitis M; Koch CM; Chan GG; Torres-Arancivia C; LaValley MP; Jacobson DR; Berk JL; Connors LH; Ruberg FL
JAMA Cardiol; 2017 Mar; 2(3):305-313. PubMed ID: 28196196
[TBL] [Abstract][Full Text] [Related]
8. Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure.
Vergaro G; Aimo A; Campora A; Castiglione V; Prontera C; Masotti S; Musetti V; Chianca M; Valleggi A; Spini V; Emdin M; Passino C
Amyloid; 2021 Dec; 28(4):252-258. PubMed ID: 34396857
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
10. Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center.
López-Sainz Á; Hernandez-Hernandez A; Gonzalez-Lopez E; Domínguez F; Restrepo-Cordoba MA; Cobo-Marcos M; Gómez-Bueno M; Hernandez-Perez FJ; Oteo JF; Mirelis JG; Cavero MA; Moñivas V; Mingo Santos S; de Haro-Del Moral FJ; Krsnik I; Salas C; Bornstein B; Briceño A; López JA; Vázquez J; Alonso-Pulpón L; Segovia J; Garcia-Pavia P
Rev Esp Cardiol (Engl Ed); 2021 Feb; 74(2):149-158. PubMed ID: 32317158
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Zumbo G; Knight DS; Kotecha T; Francis R; Hutt DF; Rezk T; Rosmini S; Quarta CC; Whelan CJ; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
J Am Coll Cardiol; 2017 Jul; 70(4):466-477. PubMed ID: 28728692
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study.
Nicol M; Vergaro G; Damy T; Kharoubi M; Baudet M; Canuti ES; Aimo A; Castiglione V; Emdin M; Royer B; Harel S; Cohen-Solal A; Arnulf B; Logeart D
Front Cardiovasc Med; 2023; 10():1179968. PubMed ID: 37600055
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Volume Fraction by Computed Tomography Predicts Long-Term Prognosis Among Patients With Cardiac Amyloidosis.
Gama F; Rosmini S; Bandula S; Patel KP; Massa P; Tobon-Gomez C; Ecke K; Stroud T; Condron M; Thornton GD; Bennett JB; Wechelakar A; Gillmore JD; Whelan C; Lachmann H; Taylor SA; Pugliese F; Fontana M; Moon JC; Hawkins PN; Treibel TA
JACC Cardiovasc Imaging; 2022 Dec; 15(12):2082-2094. PubMed ID: 36274040
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
[TBL] [Abstract][Full Text] [Related]
16. Cardiac amyloidosis diagnosed by endomyocardial biopsy. Clinical, histopathological, immunohistochemical and ultrastructural studies.
Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Michalak E; Jakubowska E; Sobieszczańska-Małek M; Deptuch T; Walczak E; Wagner T; Walski M; Rózański J; Kiedrowski M; Lubiszewska B; Hoffman P; Rózyłło W
Kardiol Pol; 2005 Jul; 63(7):20-35. PubMed ID: 16136426
[TBL] [Abstract][Full Text] [Related]
17. Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study.
Fontana M; Banypersad SM; Treibel TA; Abdel-Gadir A; Maestrini V; Lane T; Gilbertson JA; Hutt DF; Lachmann HJ; Whelan CJ; Wechalekar AD; Herrey AS; Gillmore JD; Hawkins PN; Moon JC
Radiology; 2015 Nov; 277(2):388-97. PubMed ID: 25997029
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis.
Aljama MA; Sidiqi MH; Dispenzieri A; Gertz MA; Lacy MQ; Buadi FK; Dingli D; Muchtar E; Fonder AL; Hayman SR; Hobbs MA; Gonsalves WI; Warsame RM; Kourelis T; Hwa YL; Kapoor P; Leung N; Go RS; Kyle RA; Rajkumar SV; Kumar SK
Blood Adv; 2019 Apr; 3(8):1226-1229. PubMed ID: 30975646
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis.
Quarta CC; Gonzalez-Lopez E; Gilbertson JA; Botcher N; Rowczenio D; Petrie A; Rezk T; Youngstein T; Mahmood S; Sachchithanantham S; Lachmann HJ; Fontana M; Whelan CJ; Wechalekar AD; Hawkins PN; Gillmore JD
Eur Heart J; 2017 Jun; 38(24):1905-1908. PubMed ID: 28605421
[TBL] [Abstract][Full Text] [Related]
20. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value.
Cipriani A; De Michieli L; Porcari A; Licchelli L; Sinigiani G; Tini G; Zampieri M; Sessarego E; Argirò A; Fumagalli C; De Gaspari M; Licordari R; Russo D; Di Bella G; Perfetto F; Autore C; Musumeci B; Canepa M; Merlo M; Sinagra G; Gregori D; Iliceto S; Perazzolo Marra M; Cappelli F; Rapezzi C
JACC CardioOncol; 2022 Nov; 4(4):458-470. PubMed ID: 36444225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
